John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 150,000 shares at $12.38 ($1.9M) on 2017-02-02, disclosed to the SEC on 2017-02-06.
Open-market sale of $1.9M NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.38 | 66,495 | $823K | 44.3% |
| 2 | $12.38 | 66,495 | $823K | 44.3% |
| 3 | $12.48 | 8,505 | $106K | 5.7% |
| 4 | $12.48 | 8,505 | $106K | 5.7% |
| Total | $12.39 avg | 150,000 | $1.9M | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |